Indo-MIM
Global MIM leader, new listing
- Last close
- ₹1,248.15
- 29 Sept 2026 · reference
- 1D · 1M
- +1.7% · +43.8%
- price-only
- Weight
- 0.8%
- 31 Jul 2026 · Aug rank 30
- Thesis review
- 8 Sep 2026
- Why We Own, p54
Global MIM leader, new listing — what has to happen, what we believe, what breaks it
- Q2FY27 results (Nov-2026) and first analyst day / broker initiations giving FY27-28 estimates.
- Completion of Rs 400 cr debt repayment from IPO proceeds, lowering finance cost (Rs 167 cr in FY26).
- Lock-in expiry of anchor (30 days / 90 days from 30-Jul-2026 listing) and pre-IPO shareholders (6 months, ~Jan-2027) - a supply overhang or float event.
- Global leader in a niche: ~7% share of a USD 4.0 bn (CY2025) global MIM market projected to grow 9.2% CAGR to USD 6.2 bn by CY2030; ~92% of revenue from repeat customers.
- Margin expansion visible: Q1FY27 EBITDA margin 33.4% (+400 bps YoY) with EBITDA/part rising from Rs 30 (FY24) to Rs 38 (FY26); ROE 21.3%, ROCE 26.6% (FY26).
- Diversified, defensible end-markets: defence + medical + aerospace = 49% of FY26 revenue, less cyclical than autos (25%); 77% exports across 55 countries with US/UK/Mexico plants giving tariff optionality.
- Deleveraging: Rs 400 cr of IPO proceeds earmarked to repay 33% of Rs 1,212 cr borrowings; RHP net debt/EBITDA 0.65x (FY26) vs 1.15x (FY25), D/E 0.39x.
- Growth track record: FY24-26 revenue CAGR 20.9%, PAT Rs 284 cr (FY24, RHP) to Rs 534 cr (FY26), Q1FY27 PAT +31.6%.
- Core · Mid cap0.8% of PMS · rank 30
- Customer/tariff concentration: 77% exports, top-10 customers 38% of revenue, purchase-order based with no long-term volume contracts; US/EU tariff changes directly hit demand.
- Valuation and float: stock is ~95% above IPO price at 72.6x TTM with 87% of the IPO being OFS; pre-IPO investor lock-in expiries and any quarterly wobble could de-rate the stock.
- Margin/mix: lower-margin 'others' revenue (powder, tooling) rose from 3.3% (FY24) to 15.9% (FY26) and raw-material cost rose from 16% to 21% of revenue; part volumes fell from 316 mn (FY24) to 280 mn (FY26).
Thesis and position rationale
- Investment case
- Global MIM leader, new listing
- Why this business
Indo-MIM is the world's largest metal injection moulding (MIM) component maker by revenue with ~6.8-7% global MIM market share held for six consecutive years, making 9,000+ precision parts (280 mn parts in FY26) for 1,100+ customers across automotive (24.6% of FY26 revenue), defence (18.7%), medical (18.1%), aerospace (12.0%) and consumer (10.8%). It runs 15 plants (6 India, 6 USA, 2 UK, 1 Mexico); exports were 77% of FY26 revenue and top-10 customers 38%. Listed on 30-Jul-2026 after a Rs 3,812 cr IPO (Rs 501 cr fresh + Rs 3,311 cr OFS) at Rs 485; shares opened at ~Rs 700 and closed day one at Rs 741.75 (+53%).
- What we believe
- 01Global leader in a niche: ~7% share of a USD 4.0 bn (CY2025) global MIM market projected to grow 9.2% CAGR to USD 6.2 bn by CY2030; ~92% of revenue from repeat customers.
- 02Margin expansion visible: Q1FY27 EBITDA margin 33.4% (+400 bps YoY) with EBITDA/part rising from Rs 30 (FY24) to Rs 38 (FY26); ROE 21.3%, ROCE 26.6% (FY26).
- 03Diversified, defensible end-markets: defence + medical + aerospace = 49% of FY26 revenue, less cyclical than autos (25%); 77% exports across 55 countries with US/UK/Mexico plants giving tariff optionality.
- 04Deleveraging: Rs 400 cr of IPO proceeds earmarked to repay 33% of Rs 1,212 cr borrowings; RHP net debt/EBITDA 0.65x (FY26) vs 1.15x (FY25), D/E 0.39x.
- 05Growth track record: FY24-26 revenue CAGR 20.9%, PAT Rs 284 cr (FY24, RHP) to Rs 534 cr (FY26), Q1FY27 PAT +31.6%.
- Why now
No listed history (IPO Jul-2026). Stock is ~95% above the Rs 485 IPO price, i.e. ~88x FY26 EPS vs 45x at issue; global MIM peer Jiangsu Gian trades at 148x with 3.1% RoNW. EV/EBITDA n.m.; dividend yield 0.0%.
- Market disagreement
- Sundram Fasteners: Sundram (42.5x, ROE 14.9%, FY26 PAT +Rs 593 cr) is a mature auto-fastener business growing single digits; Indo-MIM has higher ROE (21-23%), 33% EBITDA margins vs ~17%, and a global technology moat, though at a much richer 72.6x.
- Bharat Forge: Bharat Forge trades at 93.5x TTM with a Q1FY27 loss (Rs -90 cr), ROE 12% and Rs 7,309 cr debt; Indo-MIM offers higher ROE, positive Q1 growth and lower leverage at a lower multiple.
- No direct listed Indian MIM peer: The RHP names only Jiangsu Gian (China, 148x P/E, 3.1% RoNW) as a comparable; Indo-MIM's 13% PAT margin vs Gian's ~2% makes it the scarce listed play on MIM.
- Position sizing
Core Mid cap 0.8% of the PMS on $31 Jul 2026 (August rank 30). Core positions are owned through the cycle for leadership and cash-flow quality.
- Catalysts
- Q2FY27 results (Nov-2026) and first analyst day / broker initiations giving FY27-28 estimates.
- Completion of Rs 400 cr debt repayment from IPO proceeds, lowering finance cost (Rs 167 cr in FY26).
- Lock-in expiry of anchor (30 days / 90 days from 30-Jul-2026 listing) and pre-IPO shareholders (6 months, ~Jan-2027) - a supply overhang or float event.
- Risks and response
- Customer/tariff concentration: 77% exports, top-10 customers 38% of revenue, purchase-order based with no long-term volume contracts; US/EU tariff changes directly hit demand.
- Valuation and float: stock is ~95% above IPO price at 72.6x TTM with 87% of the IPO being OFS; pre-IPO investor lock-in expiries and any quarterly wobble could de-rate the stock.
- Margin/mix: lower-margin 'others' revenue (powder, tooling) rose from 3.3% (FY24) to 15.9% (FY26) and raw-material cost rose from 16% to 21% of revenue; part volumes fell from 316 mn (FY24) to 280 mn (FY26).
- Thesis-break conditions
- Not stated separately on this page; the risk list carries the monitoring triggers.
- Review history
- 8 Sep 2026 · Yash Palod · one-pager in "Why We Own What We Own" (p54) · portfolio as of $31 Jul 2026
- 31 Aug 2026 · Classification in the August top-30: Core
Source: Buoyant_Why_We_Own_What_We_Own_Sep2026.pdf (portfolio as of 31 July 2026), p54. Internal; external publication of these fields is controlled by audience policy.
Internal actions
- HoldPosition carried into August at rank 30.
- ReviewNext scheduled: post 2QFY27 results (Oct–Nov 2026).
Add/trim/exit decisions require transactions data; none supplied. Recording a decision needs a persistence adapter (not configured).
Sector datapoints
- Global metal injection moulding market: USD 4.0 bn in CY2025, projected USD 6.2 bn by CY2030 (9.2% CAGR) (FundsIndia IPO note citing RHP industry report, Jul-2026).
- Indo-MIM held ~6.8% of global MIM revenue for six consecutive years and is the largest MIM manufacturer globally (RHP via FundsIndia/ipoanalysis, Jul-2026).
- Indo-MIM IPO: Rs 3,812 cr (7.86 cr shares) at Rs 485, listed 30-Jul-2026 at Rs 700-703, closed Rs 741.75 (+53%); lead managers HDFC Bank, Axis, ICICI Sec, Kotak, SBI Caps (Chittorgarh).
- Union Budget FY27 raised the Electronics Component Manufacturing Scheme outlay to Rs 40,000 cr and central capex to Rs 12.2 lakh cr, supporting domestic precision-component demand (PIB, Feb-2026).